A fully human antibody showed promise against aggressive prostate cancer in preclinical testing. For most men diagnosed with prostate cancer, the disease grows slowly. The danger changes sharply when cancer cells begin to leave the prostate and spread to the lymph nodes or bones, where treatment becomes harder, and the stakes rise. Researchers at Umeå […]This is a curated summary.